false

Cullen Taylor

Founder of the uniquely consultative biospecimens company GLAS •Research interests and expertise: Fine Needle Aspiration and exfoliative cytopathology, Surgical Pathology, Uropathology •Board Certification: American Board of Pathology Cytopathology, American Board of Pathology Anatomic and Clinical Pathology

• Read: Case Study: Managing Complexity in an Autologous Cell Therapy Trial

  Clinical Trials

  Case Study: Managing Complexity in an Autologous Cell Therapy Trial

  Sep 22, ‘26 | 8 min read

  • 

  • Deborah S.

    Saoussen B.

    Jack S.

  Discover
• Read: How Investigator Engagement Builds Enrollment Momentum

  Clinical Trials

  How Investigator Engagement Builds Enrollment Momentum

  Sep 21, ‘26 | 6 min read

  • 

    Lisa Lopez

  Discover
• Read: Case Study: Nectin 4 Biomarker Testing for Oncology Clinical Programs

  Translational Research

  Case Study: Nectin 4 Biomarker Testing for Oncology Clinical Programs

  Sep 14, ‘26 | 3 min read

  • 

    Christie Bongel

  Discover
• Read: Has the rest of the world finally caught up with Latin America?

  Clinical Trials

  Has the rest of the world finally caught up with Latin America?

  Sep 02, ‘26 | 5 min read

  • 

    Andrés Bayona

  Discover
• Read: Case Study: Rapid Execution of Assay Validation Rescued Global Study

  Translational Research - Assays

  Case Study: Rapid Execution of Assay Validation Rescued Global Study

  Aug 20, ‘26 | 7 min read

  • 

  • Christie B.

    Kennon D.

  Discover
• Read: Clinical AI at Scale: Why Trust Matters More Than Speed

  Clinical Trials

  Clinical AI at Scale: Why Trust Matters More Than Speed

  Aug 18, ‘26 | 6 min read

  • 

  • Zulfat K.

    Shakila J.

    Sugumaran M.

  Discover
• Read: Hidden Strategic Edge in Clinical Trials: Financial Project Management

  Clinical Trials

  Hidden Strategic Edge in Clinical Trials: Financial Project Management

  Aug 17, ‘26 | 5 min read

  • 

    Romy Kane

  Discover
• Read: Why Most Early Autoimmune Trials Fail to Yield Decision-ready Evidence

  Early Phase Research - Autoimmune

  Why Most Early Autoimmune Trials Fail to Yield Decision-ready Evidence

  Aug 10, ‘26 | 6 min read

  • 

    Rui F Duarte-Lopes

  Discover
• Read: Why Global Oncology Evidence May Not Support U.S. Regulatory Approval

  Clinical Trials - Regulatory

  Why Global Oncology Evidence May Not Support U.S. Regulatory Approval

  Aug 03, ‘26 | 9 min read

  • 

    Harpreet Singh, MD

  Discover

Loading...

You've reach the end Back to top